Systemic Sclerosis Clinical Trials

444 clinical trials for Systemic Sclerosis across international registries, including 117 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis — RECRUITING · PHASE2
• DERMATOMICS: Identifying Regulators of Skin Homeostasis — RECRUITING
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease — RECRUITING · PHASE1
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) — RECRUITING · PHASE1
• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — RECRUITING · PHASE3
• A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases — RECRUITING · PHASE1
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. — RECRUITING · PHASE2
• A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease — RECRUITING · PHASE1
• CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH — RECRUITING · PHASE1
• A Study of AZD0120 in Autoimmune Diseases — RECRUITING · PHASE1
• RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis — RECRUITING · PHASE1
• A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — RECRUITING · PHASE2
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study — RECRUITING · PHASE2
• Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk — RECRUITING · PHASE2
• Systemic Sclerosis DIet for GastrointESTinal Symptoms — RECRUITING · NA
• MTS109 in Patients With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Controlling Hyperactive Immunity With Long-lived Lymphocytes — RECRUITING · PHASE1
• Immun4Cure Cohort of Autoimmune Diseases — RECRUITING
• Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking — RECRUITING
• A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. — RECRUITING · PHASE1
• A Study of KITE-363 in Participants With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• US Zamto-cel Autoimmune Diseases — RECRUITING · PHASE1
• Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis — RECRUITING · NA
• EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases — RECRUITING
• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease — RECRUITING · PHASE1
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases — RECRUITING · PHASE1
• Intralesional Injection of STS in Treatment of Calcinosis — RECRUITING · PHASE2
• Deployment o the Multidisciplinary Prospective Cohort Imminent — RECRUITING · NA
• Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases — RECRUITING · NA
• National paediatric rheumatologic database — RECRUITING
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders — RECRUITING · PHASE1
• Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease — RECRUITING · PHASE3
• Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease — RECRUITING · PHASE1
• A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis — RECRUITING · PHASE2
• Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis — RECRUITING · PHASE2
• A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease — RECRUITING · PHASE1
• Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis — RECRUITING
• Hand Disability In Systemic Sclerosis - Digital Ulcers — RECRUITING
• CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) — RECRUITING · PHASE1
• Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. — RECRUITING · PHASE1
• Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases — RECRUITING · PHASE1
• Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images — RECRUITING
• A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Rheumatology Patient Registry and Biorepository — RECRUITING
• A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 — RECRUITING

Refine this search